查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1405849

IVD（体外诊断）用酶的市场规模、份额和趋势分析报告：按酶类型、疾病类型、技术类型、最终用途、地区和细分市场预测，2023-2030 年

In-vitro Diagnostics Enzymes Market Size, Share & Trends Analysis Report By Enzyme Type (Polymerase & Transcriptase, Proteases), By Disease Type, By Technology Type, By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 199 Pages | 商品交期: 2-10个工作天内

价格

IVD（体外诊断）酵素市场的成长与趋势：

Grand View Research, Inc.最新报告显示，预计2023年至2030年全球IVD（体外诊断）酵素市场规模将以7.9%的复合年增长率成长，2030年达到37亿美元。

临床疾病的准确、快速诊断和治疗对于最佳临床结果至关重要。由于其显着的生物催化特性，酶被用于诊断多种疾病。

酵素生物感测器的发展增加了酵素在临床诊断中的效用。儘管在临床诊断方面有需求，但生物感测器的商业化和从研究到临床的转化仍然很低。然而，随着研究和开发工作的不断增加，乳酸、胆固醇和葡萄糖生物感测器正在商业化用于诊断用途。

蛋白酶是重要的讯号蛋白，对于多种病理过程至关重要，包括癌症、神经系统疾病、发炎疾病和心血管疾病。预计聚合酶和转录酶在预测期内将表现出最快的复合年增长率。此外，大量提供这些酶的参与者的存在预计将推动成长。 Kaneka Eurogentec SA、Toyobo Co., Ltd. 和 Sekisui Diagnostics, LLC 等主要企业生产和销售各种聚合酶，包括 KOD DNA 聚合酶、Taq DNA 聚合酶、Tth DNA 聚合酶和 TTx DNA 聚合酶。

2019年，感染疾病领域占据市场主导地位。全球范围内 COVID-19 病例的快速增加正在推动诊断酶用于 COVID-19 诊断的采用率。基于即时 PCR、LAMP-PCR（环介导等温扩增 -PCR）、多重 PCR 和数位 PCR 技术的定性和定量分子检测在感染疾病诊断中的应用不断增加，导致酶的可用性不断提高这个细分市场正在推动需求。

酵素免疫组织化学 (IHC) 因其更好的对比度以及与用于检测目标成分的多种染色技术的兼容性而成为组织学的首选。体外诊断 (IVD) 酵素可用于多种最终应用，用于分析组织检体和体液。体外诊断 (IVD) 酶被广泛的最终用户使用，包括每天执行多次分析的大型实验室和执行少量测试的小型诊所。

2019 年，北美成为一个重要的区域市场。癌症患者数量的增加以及采用酵素对切片检查样本进行组织病理学检查是预计推动该地区市场成长的其他一些因素。据预测，更大的目标人口、改善的医疗基础设施、未满足的临床需求、政府倡议的增加以及先进诊断技术倡议活动的增加将推动亚太市场以最快的速度成长。

市场上的主要企业正在参与新产品发布、收购、联盟、合作伙伴关係和地理扩张，以提高其在市场中的影响力。例如，2020年6月，Codexis, Inc.与Alphazyme LLC签订了合作协议，生产和联合行销高保真DNA聚合酶、T7 RNA聚合酶和逆转录酶。

IVD（体外诊断）酵素市场报告亮点

  • 按酶类型划分，聚合酶和转录酶由于在分子诊断检测中的广泛应用，在 2022 年占据最大份额。
  • 按疾病类型划分，预计感染疾病领域将在整个预测期主导市场。
  • 按技术类型划分，由于组织学检测在癌症诊断中的效用以及各种癌症类型盛行率的上升，到 2022 年，组织学检测细分市场将占据最大份额。
  • 从最终用途来看，医院和诊断实验室将在 2022 年占据市场主导地位。由于住院患者的增加和癌症患者入院人数的增加，用于组织病理学和细胞病理学的切片检查检体大量涌入这些设施。
  • 由于该地区存在大量参与者，例如 Innovative Research、Bio-Rad Laboratories, Inc.、Rockland Nutrition, Inc.、MyBioSource.com、RayBiotech, Inc.，北美将在 2022 年主导整个市场。 。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章 IVD（体外诊断）酵素市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 普及和成长前景图
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • IVD（体外诊断）酵素市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第 4 章 IVD（体外诊断）酵素：产品评估与趋势分析

  • IVD（体外诊断）酵素市场：重点
  • IVD（体外诊断）酵素市场：2022 年和 2030 年趋势和市场占有率分析
  • 蛋白酶
  • 聚合酶和转录酶
  • 核糖核酸酶
  • 其他的

第五章 IVD（体外诊断）酵素：疾病类型的估计和趋势分析

  • IVD（体外诊断）酵素市场：重点
  • IVD（体外诊断）酵素市场：2022 年和 2030 年趋势和市场占有率分析
  • 感染疾病
  • 糖尿病
  • 肿瘤学
  • 心臟病学
  • 肾臟病学
  • 自体免疫疾病
  • 其他的

第六章 IVD（体外诊断）酵素：技术评估与趋势分析

  • IVD（体外诊断）酵素市场：重点
  • IVD（体外诊断）酵素市场：2022 年和 2030 年趋势和市场占有率分析
  • 组织学检测
  • 分子诊断
  • 临床化学

第 7 章 IVD（体外诊断）用酵素：最终用途的估计与趋势分析

  • IVD（体外诊断）酵素市场：重点
  • IVD（体外诊断）酵素市场：2022 年和 2030 年趋势和市场占有率分析
  • 製药和生物技术
  • 医院和诊断实验室
  • 学术实验室

第八章 IVD（体外诊断）酵素市场：区域估计与趋势分析

  • 区域展望
  • 按地区分類的 IVD（体外诊断）酵素市场：主要市场点
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 科威特

第9章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争分类
    • Merck KGaA
    • Codexis, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Amano Enzymes Inc.
    • Advanced Enzymes Technologies Ltd.
    • Biocatalysts Ltd.
    • Amicogen
    • Dyadic International
    • BBI Solutions
    • Affymetrix
    • American Laboratories
Product Code: GVR-4-68039-246-6

In-vitro Diagnostics Enzymes Market Growth & Trends:

The global in-vitro diagnostics enzymes market size is expected to reach USD 3.70 billion by 2030, expanding at a CAGR of 7.9% from 2023 to 2030, according to a new report by Grand View Research, Inc. Accurate and rapid diagnosis and treatment of clinical disorders are essential for optimal clinical outcomes. Owing to the noteworthy biocatalytic properties, enzymes are used in the diagnosis of a wide range of diseases.

The development of enzyme biosensors has increased the enzyme utility in clinical diagnostics. Despite the necessity in clinical diagnosis, the commercialization and translation of biosensors from research to clinics are still low. However, with an increase in R&D efforts, lactate, cholesterol, and glucose biosensors have been commercialized for diagnostic use.

Proteases are important signaling proteins that are critical to a few pathological processes, including cancer, neurological, inflammatory, and cardiovascular disorders. Polymerase and transcriptase enzymes are expected to exhibit the fastest CAGR over the forecast period. In addition, the presence of a substantial number of players that offer these enzymes is expected to enhance the growth. Key players such as Kaneka Eurogentec S.A.; Toyobo Co., Ltd.; and Sekisui Diagnostics, LLC manufacture and distribute a wide range of polymerases, including KOD DNA Polymerase, Taq DNA Polymerase, Tth DNA Polymerase, and TTx DNA Polymerase.

The infectious disease segment dominated the market in 2019. An exponential rise in the COVID-19 cases globally drives the adoption rate of diagnostic enzymes for COVID-19 diagnosis. An increase in the availability of qualitative and quantitative molecular assays based on real-time PCR, Loop-mediated Isothermal Amplification- PCR (LAMP-PCR), multiplex PCR, and digital PCR technologies for the diagnosis of infectious diseases drives the demand for enzymes in this segment.

Enzymatic immunohistochemistry (IHC) is preferred for histology owing to a better contrast ratio and the method's compatibility for use with multiple stains for the detection of target components. IVD enzymes are employed in different end-use settings for the analysis of tissue specimens and bodily fluids. A wide range of end users including large laboratories that conduct multiple analyses in a day and smaller clinics that conduct a few tests use enzymes for in-vitro diagnostics (IVD).

North America emerged as a prominent regional market in 2019. A rise in the number of cancer cases and the adoption of enzymes for histopathology of biopsy samples are some of the other factors expected to propel market growth in the region. The presence of a large target population, improvements in healthcare infrastructure, high unmet clinical needs, increase in government initiatives, and rise in R&D activities for advanced diagnostic techniques are anticipated to drive the Asia Pacific market with the fastest growth rate.

The key players in the market are involved in novel product launches, acquisitions, collaborations, partnerships, and geographical expansions to reinforce their market presence. For instance, in June 2020, Codexis, Inc. signed a collaboration agreement with Alphazyme LLC for the manufacture and co-marketing of high-fidelity DNA polymerase, T7 RNA polymerase, and reverse transcriptase.

In-vitro Diagnostics Enzymes Market Report Highlights:

  • By enzyme type, polymerase and transcriptase enzymes held the largest share in 2022 owing to their wide applications in molecular diagnostic assays
  • Based on disease type, the infectious disease segment is expected to dominate the market throughout the forecast period
  • In terms of technology type, the histology assays segment held the largest share in 2022 owing to the utility of histology assays in cancer diagnostics, coupled with a rising incidence of different cancer types
  • By end use, hospital and diagnostic labs dominated the market in 2022. They witness a high inflow of biopsy specimens for histopathology and cytopathology because of an increase in hospitalization and rise in the number of hospital admissions for cancer patients
  • North America dominated the overall market in 2022 owing to the presence of a substantial number of players in this region including Innovative Research; Bio-Rad Laboratories, Inc.; Rockland Immunochemicals, Inc.; MyBioSource.com; and RayBiotech, Inc.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Enzyme Type
    • 1.1.2. Disease Type
    • 1.1.3. Technology Type
    • 1.1.4. End use
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Enzyme type outlook
    • 2.2.2. Disease type outlook
    • 2.2.3. Technology type outlook
    • 2.2.4. End use outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. In-Vitro Diagnostics Enzymes Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. In-Vitro Diagnostics Enzymes Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. In-Vitro Diagnostics Enzymes: Product Estimates & Trend Analysis

  • 4.1. In-Vitro Diagnostics Enzymes Market: Key Takeaways
  • 4.2. In-Vitro Diagnostics Enzymes Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Proteases
    • 4.3.1. Proteases market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Polymerase & Transcriptase
    • 4.4.1. Polymerase & Transcriptase market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Ribonuclease
    • 4.5.1. Ribonuclease market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. In-Vitro Diagnostics Enzymes: Disease Type Estimates & Trend Analysis

  • 5.1. In-Vitro Diagnostics Enzymes Market: Key Takeaways
  • 5.2. In-Vitro Diagnostics Enzymes Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Infectious Disease
    • 5.3.1. Infectious Disease market estimates and forecasts, 2018 to 2030 (USD Million)
      • 5.3.1.1. COVID -19 Testing
      • 5.3.1.1.1. COVID-19 testing market estimates and forecasts, 2018 to 2030 (USD Million)
      • 5.3.1.2. Hepatitis
      • 5.3.1.2.1. Hepatitis market estimates and forecasts, 2018 to 2030 (USD Million)
      • 5.3.1.3. HIV
      • 5.3.1.3.1. HIV market estimates and forecasts, 2018 to 2030 (USD Million)
      • 5.3.1.4. Others
      • 5.3.1.4.1. Other testing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Diabetes
    • 5.4.1. Diabetes market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Oncology
    • 5.5.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Cardiology
    • 5.6.1. Cardiology market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Nephrology
    • 5.7.1. Nephrology market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.8. Autoimmune Diseases
    • 5.8.1. Autoimmune diseases market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. In-Vitro Diagnostics Enzymes: Technology Estimates & Trend Analysis

  • 6.1. In-Vitro Diagnostics Enzymes Market: Key Takeaways
  • 6.2. In-Vitro Diagnostics Enzymes Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Histology Assays
    • 6.3.1. Histology Assays market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Molecular Diagnostics
    • 6.4.1. Molecular diagnostics market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.4.1.1. PCR Assays
      • 6.4.1.1.1. PCR assays market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.4.1.2. NGS Assays
      • 6.4.1.2.1. NGS assays market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.4.1.3. Others
      • 6.4.1.3.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Clinical Chemistry
    • 6.5.1. Clinical chemistry market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. In-Vitro Diagnostics Enzymes : End Use Estimates & Trend Analysis

  • 7.1. In-Vitro Diagnostics Enzymes Market: Key Takeaways
  • 7.2. In-Vitro Diagnostics Enzymes Market: Movement & Market Share Analysis, 2022 & 2030
  • 7.3. Pharma & Biotech
    • 7.3.1. Pharma & Biotech market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4. Hospital & Diagnostic Labs
    • 7.4.1. Hospital & Diagnostic Lab market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. Academic Labs
    • 7.5.1. Academic Lab market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. In-Vitro Diagnostics Enzymes Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Outlook
  • 8.2. In-Vitro Diagnostics Enzymes Market by Region: Key Marketplace Takeaway
  • 8.3. North America
    • 8.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.4. Europe
    • 8.4.1. U.K.
      • 8.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.3. France
      • 8.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.4. Italy
      • 8.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.5. Spain
      • 8.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.6. Sweden
      • 8.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.7. Norway
      • 8.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.8. Denmark
      • 8.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Japan
      • 8.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.2. China
      • 8.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.3. India
      • 8.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.4. Australia
      • 8.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.5. Thailand
      • 8.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.6. South Korea
      • 8.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.6.2. Mexico
      • 8.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.7. MEA
    • 8.7.1. Saudi Arabia
      • 8.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.7.4. Kuwait
      • 8.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
    • 9.2.1. Merck KGaA
      • 9.2.1.1. Company overview
      • 9.2.1.2. Financial performance
      • 9.2.1.3. Product benchmarking
      • 9.2.1.4. Strategic initiatives
    • 9.2.2. Codexis, Inc.
      • 9.2.2.1. Company overview
      • 9.2.2.2. Financial performance
      • 9.2.2.3. Product benchmarking
      • 9.2.2.4. Strategic initiatives
    • 9.2.3. F. Hoffmann-La Roche Ltd.
      • 9.2.3.1. Company overview
      • 9.2.3.2. Financial performance
      • 9.2.3.3. Product benchmarking
      • 9.2.3.4. Strategic initiatives
    • 9.2.4. Amano Enzymes Inc.
      • 9.2.4.1. Company overview
      • 9.2.4.2. Financial performance
      • 9.2.4.3. Product benchmarking
      • 9.2.4.4. Strategic initiatives
    • 9.2.5. Advanced Enzymes Technologies Ltd.
      • 9.2.5.1. Company overview
      • 9.2.5.2. Financial performance
      • 9.2.5.3. Product benchmarking
      • 9.2.5.4. Strategic initiatives
    • 9.2.6. Biocatalysts Ltd.
      • 9.2.6.1. Company overview
      • 9.2.6.2. Financial performance
      • 9.2.6.3. Product benchmarking
      • 9.2.6.4. Strategic initiatives
    • 9.2.7. Amicogen
      • 9.2.7.1. Company overview
      • 9.2.7.2. Financial performance
      • 9.2.7.3. Product benchmarking
      • 9.2.7.4. Strategic initiatives
    • 9.2.8. Dyadic International
      • 9.2.8.1. Company overview
      • 9.2.8.2. Financial performance
      • 9.2.8.3. Product benchmarking
      • 9.2.8.4. Strategic initiatives
    • 9.2.9. BBI Solutions
      • 9.2.9.1. Company overview
      • 9.2.9.2. Financial performance
      • 9.2.9.3. Product benchmarking
      • 9.2.9.4. Strategic initiatives
    • 9.2.10. Affymetrix
      • 9.2.10.1. Company overview
      • 9.2.10.2. Financial performance
      • 9.2.10.3. Product benchmarking
      • 9.2.10.4. Strategic initiatives
    • 9.2.11. American Laboratories
      • 9.2.11.1. Company overview
      • 9.2.11.2. Financial performance
      • 9.2.11.3. Product benchmarking
      • 9.2.11.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 3 North America in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 4 North America in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 5 North America in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 6 North America in-vitro diagnostics enzymes market, by region, 2018 - 2030 (USD Million)
  • Table 7 U.S. in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 8 U.S. in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 9 U.S. in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 10 U.S. in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Canada in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 12 Canada in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 13 Canada in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 14 Canada in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Europe in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 16 Europe in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 17 Europe in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 18 Europe in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe in-vitro diagnostics enzymes market, by region, 2018 - 2030 (USD Million)
  • Table 20 Germany in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 21 Germany in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 22 Germany in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 23 Germany in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 24 UK in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 25 UK in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 26 UK in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 27 UK in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 28 France in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 29 France in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 30 France in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 31 France in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 33 Italy in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 34 Italy in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 35 Italy in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 36 Spain in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 37 Spain in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 38 Spain in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 39 Spain in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Sweden in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 41 Sweden in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 42 Sweden in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 43 Sweden in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Norway in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 45 Norway in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 46 Norway in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 47 Norway in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Denmark in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 49 Denmark in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 50 Denmark in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 51 Denmark in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Asia Pacific in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 53 Asia Pacific in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 54 Asia Pacific in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 55 Asia Pacific in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific in-vitro diagnostics enzymes market, by region, 2018 - 2030 (USD Million)
  • Table 57 China in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 58 China in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 59 China in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 60 China in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Japan in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 62 Japan in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 63 Japan in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 64 Japan in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 65 India in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 66 India in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 67 India in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 68 India in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Australia in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 70 Australia in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 71 Australia in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 72 Australia in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Thailand in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 74 Thailand in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 75 Thailand in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 76 Thailand in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 77 South Korea in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 78 South Korea in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 79 South Korea in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 80 South Korea in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 81 Latin America in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 82 Latin America in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 83 Latin America in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 84 Latin America in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 85 Latin America in-vitro diagnostics enzymes market, by region, 2018 - 2030 (USD Million)
  • Table 86 Brazil in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 87 Brazil in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 88 Brazil in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 89 Brazil in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 90 Mexico in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 91 Mexico in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 92 Mexico in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 93 Mexico in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 94 Argentina in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 95 Argentina in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 96 Argentina in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 97 Argentina in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 98 Middle East and Africa in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 99 Middle East and Africa in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 100 Middle East and Africa in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 101 Middle East and Africa in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 102 Middle East and Africa in-vitro diagnostics enzymes market, by region, 2018 - 2030 (USD Million)
  • Table 103 South Africa in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 104 South Africa in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 105 South Africa in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 106 South Africa in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 111 UAE in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 112 UAE in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 113 UAE in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 114 UAE in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 115 Kuwait in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 116 Kuwait in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 117 Kuwait in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 118 Kuwait in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 In-vitro diagnostics enzymes: Market outlook
  • Fig. 9 In-vitro diagnostics enzymes: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 In-vitro diagnostics enzymes market driver impact
  • Fig. 15 In-vitro diagnostics enzymes market restraint impact
  • Fig. 16 In-vitro diagnostics enzymes market strategic initiatives analysis
  • Fig. 17 In-vitro diagnostics enzymes market: Enzyme type movement analysis
  • Fig. 18 In-vitro diagnostics enzymes market: Enzyme type outlook and key takeaways
  • Fig. 19 Proteases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Polymerase & transcriptase market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Ribonuclease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 In-vitro diagnostics enzymes market: Disease type movement analysis
  • Fig. 24 In-vitro diagnostics enzymes market: Disease type outlook and key takeaways
  • Fig. 25 Infectious disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Diabetes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Cardiology market estimates and forecasts, 2018 - 2030
  • Fig. 29 Nephrology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Autoimmune diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 In-vitro diagnostics enzymes market: Technology type movement analysis
  • Fig. 33 In-vitro diagnostics enzymes market: Technology type outlook and key takeaways
  • Fig. 34 Histology assays market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Clinical chemistry market estimates and forecasts, 2018 - 2030
  • Fig. 37 Others market estimates and forecasts, 2018 - 2030
  • Fig. 38 In-vitro diagnostics enzymes market: End use type movement analysis
  • Fig. 39 In-vitro diagnostics enzymes market: End use type outlook and key takeaways
  • Fig. 40 Pharma & biotech market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Hospital & diagnostic labs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Contract Research Organizations (CROs) market estimates and forecasts, 2018 - 2030
  • Fig. 43 Academic labs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Global in-vitro diagnostics enzymes market: Regional movement analysis
  • Fig. 45 Global in-vitro diagnostics enzymes market: Regional outlook and key takeaways
  • Fig. 46 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 U.K. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)